Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective

Jones, HM, Chen, Y, Gibson, C, Heimbach, T, Parrott, N, Peters, SA, Snoeys, J, Upreti, VV +2 more·2015·Clinical Pharmacology & Therapeutics
DOI 10.1002/cpt.37

Cited by (487)

Items 401–487 of 487

  1. A Comprehensive Physiologically Based Pharmacokinetic Framework of Ofloxacin: Predicting Disposition in Renal Impairment
    Ammara Zamir, Muhammad Fawad Rasool, Iltaf Hussain, Sary Alsanea, Samiah A. Alhabardi, Faleh Alqahtani · 2025 · Pharmaceutics
  2. NANO-ENABLED THERAPEUTICS: EXPLORING BIOEQUIVALENCE AND BIOAVAILABILITY FRONTIERS
    Aravinda Pai, K. S. Chandrashekar, BHAVANA BHAT B., VIDHI ANSUL SAXENA, Venkatesh Kamath B · 2025 · International Journal of Applied Pharmaceutics
  3. Drug–Drug Interactions: Computational Approaches
    K Rowland‐Yeo, Geoffrey T. Tucker · 2015 · Royal Society of Chemistry eBooks
  4. Views on the Therapeutic Needs of Older Adults
    S. W. Johnny Lau, Raman K. Baweja · 2016 · AAPS advances in the pharmaceutical sciences series
  5. Human PK Prediction and Modeling
    Thaddeus H. Grasela, V. Lukacova, Denise Morris, Richard D. Clark, Kayla Ann Andrews, Michael B. Bolger · 2016 · Elsevier eBooks
  6. Role of Systems Modeling in Regulatory Drug Approval
    Vikram P. Sinha, Shiew-Mei Huang, Darrell R. Abernethy, Yaning Wang, Ping Zhao, Issam Zineh · 2016 · AAPS advances in the pharmaceutical sciences series
  7. Stereoselective biosynthesis of 3′-azido-3′-deoxythymidine 5′-O-β-D-ribopyranoside and in vitro evaluation as potential antileishmanial with in silicoADME prediction
    Evilanna Lima Arruda, Elaine Sousa Nunes, Kamila Bohne Japiassu, Paula Letícia de Melo Souza, Kelly Carolina Frauzino Araújo Cordeiro, Marina Clare Vinaud, Valéria de Oliveira · 2019 · Process Biochemistry
  8. Integration of Engineered Delivery with the Pharmacokinetics of Medical Candidates via Physiology-Based Pharmacokinetics
    Yuching Yang, Xinyuan Zhang · 2022 · Methods in molecular biology
  9. Paving the Path for Increased Technological Innovation, Strategic Decision Making and Regulatory Acceptance of Modeling and Simulation Approaches
    Lanyan Fang, Eleftheria Tsakalozou, James E. Polli · 2025 · Pharmaceutical Research
  10. Confidence Assessment of an Absorption Model Using Limited Solubility and Permeability Data for 21 Drugs within a Dynamic Physiologically-Based Pharmacokinetic Simulator
    Stewart C. Wang, Mingxiang Liao, Cindy Q. Xia · 2015 · Journal of Applied Biopharmaceutics and Pharmacokinetics
  11. Application and Impact of Human Dose Projection from Discovery to Early Drug Development
    Dipal Patel, Wenzhan Yang, Maya P. Lipert, Tian Wu · 2020 · AAPS PharmSciTech
  12. Applications of Pediatric PBPK Modeling: Current Status for Drug Development Processes and Use in Clinical Settings
    Chie Emoto, Tsuyoshi Fukuda · 2020 · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
  13. Translational Medicine: Enabling the Proof of Concepts
    Gëzim Lahu, John Darbyshire · 2016
  14. Prediction of Human Pharmacokinetics and Pharmacodynamics
    Ulf Bredberg · 2018 · Methods and principles in medicinal chemistry
  15. APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC AND PHARMACODYNAMIC (PBPK/PD) MODELING COMPRISING TRANSPORTERS
    Matthew D. Harwood, Amin Rostami‐Hodjegan, Sibylle Neuhoff · 2022 · Wiley eBooks
  16. Research and development of nanosized drug containing nasal drug delivery systems to reach systemic and central nerve system effect
    Péter Gieszinger · 2020
  17. Application of mechanistic multiparameter optimization and large scale in vitro to in vivo pharmacokinetics correlations to small molecule therapeutic projects
    Fabio Broccatelli, Vijayabhaskar Veeravalli, Daniel K. Cashion, Javier L. Baylon, Franco Lombardo, Lei Jia · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Integrated Lead Optimization: Translational Models as We Advance Toward the Clinic
    Bianca M. Liederer, Xingrong Liu, Simon G.W. Wong, Daniel R. Mudra · 2017 · AAPS advances in the pharmaceutical sciences series
  19. EFFECT OF ETHANOL ON GASTROINTESTINAL TIGHT JUNCTIONS AND P-GLYCOPROTEIN EXPRESSION AND FUNCTIONALITY
    Armin Sadighi · 2018
  20. Application Of Quantitative Pharmacological Modeling To Improve Drug Therapy In Older Adults
    Chay Ngee Lim · 2016 · University of Minnesota Digital Conservancy (University of Minnesota)
  21. Mechanistic Physiologically based Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Models to Evaluate the Mutual Relationships between an Acid Pump Antagonist and Intragastric pH in Humans
    이현아 · 2019
  22. Physiologically based pharmacokinetic models to support modernized chemical safety assessment
    Miyoung Yoon · 2020 · Elsevier eBooks
  23. Assessment of Exposures in Vulnerable Populations: Exposure and Response Modelling for Environmental Contaminants Through a Lifetime
    Jennifer Ann Lowry · 2019 · Encyclopedia of the UN sustainable development goals
  24. The role of quantitative modeling and simulation in translational science
    Venkatesh Pilla Reddy, Andy Zhu · 2020 · Elsevier eBooks
  25. Qualification and application of liquid chromatography-quadrupole time-of-flight mass spectrometric method for the determination of carisbamate in rat plasma and prediction of its human pharmacokinetics using physiologically based pharmacokinetic modeling
    Byeong ill Lee, Jeong-Hyeon Lim, Min‐Ho Park, Seok‐Ho Shin, Jin‐Ju Byeon, Jangmi Choi, Seojin Park, Min-Jae Park, Yuri Park, Young Geun Shin · 2020 · Translational and Clinical Pharmacology
  26. Application Of A Physiologically-Based Pharmacokinetic (PBPK) Model In Predicting Drug Interactions
    Maya P. Radeva-Ilieva, Kaloyan Georgiev · 2020 · Annual for Hospital Pharmacy
  27. JURISPRUDENCIA. Conflicto de competencia: Impuestos
    Rosa María Galán Sánchez · 2010 · Derecho de los negocios
  28. Enabling personalized medicine through pharmacokinetic modeling
    Megerle L. Scherholz · 2019
  29. Aumento del tiempo de reverberación del escenario de un auditorio mediante control activo
    Miguel David Betancourt López, Nicolás Calderón González · 2013 · Digital Library (University of San Buenaventura Colombia)
  30. Biopharmaceutics to Inform Candidate Drug Selection and Optimisation
    Linette Ruston · 2021
  31. EPILOGUE
    Sheila Annie Peters · 2021
  32. PBPK MODELING AND SIMULATIONS TO EVALUATE CLINICAL DRUG‐DRUG INTERACTIONS
    Sheila Annie Peters · 2021
  33. NONCLINICAL, CLINICAL, AND MODEL‐INFORMED DRUG DEVELOPMENT
    Sheila Annie Peters · 2021
  34. ABSORPTION‐RELATED APPLICATIONS OF PBPK MODELING
    Sheila Annie Peters · 2021
  35. Regional Intestinal Drug Absorption
    Maria Isabel Gonzalez-Alvarez, Arik Dahan · 2022 · MDPI eBooks
  36. Physiologically Based Pharmacokinetic (PBPK) Modeling: Applications in Drug Development
    Manuel Ibarra, Alejandra Schiavo, Lawrence J. Lesko · 2021 · Springer eBooks
  37. Assessment of Exposures in Vulnerable Populations: Exposure and Response Modelling for Environmental Contaminants Through a Lifetime
    Jennifer Ann Lowry · 2019 · Encyclopedia of the UN sustainable development goals
  38. Physiologically Based Pharmacokinetic (PBPK) Modeling: Model Development and Evaluation
    Manuel Ibarra, Alejandra Schiavo, Lawrence J. Lesko · 2021 · Springer eBooks
  39. Physiologically Based Pharmacokinetic (PBPK) Modeling: Applications in Drug Development
    Manuel Ibarra, Alejandra Schiavo, Lawrence J. Lesko · 2022 · Springer eBooks
  40. Taming the Beast: How to Optimize DMPK–PD Properties of Oral Degraders
    Caroline Rynn, Arthur J. Van De Vyver, Antje‐Christine Walz, Carina Cantrill, Matthias Wittwer · 2022
  41. Physiologically based population pharmacokinetic/pharmacodynamic modeling and simulation approaches to support waivers of in vivo clinical pharmacology studies
    Ioannis Loisios-Konstantinidis · 2022
  42. Research on the strategy of using graphic creativity in visual communication design in the context of Internet+
    Huali Lan · 2023 · Applied Mathematics and Nonlinear Sciences
  43. PBPK modeling for early clinical study decision making
    Arian Emami Riedmaier · 2023 · Elsevier eBooks
  44. Virtual packaging model construction of visual images for visual communication in the context of modern information convergence
    Dan Gao, Wei Feng, Haibo Wang, Yaquan Wang · 2023 · Applied Mathematics and Nonlinear Sciences
  45. Pharmacometric approaches to improve theranostics
    Hinke Siebinga · 2023
  46. Estimating Organ-to-Plasma Ratios in physiologically based PK modeling: a simplified approach for early drug discovery
    Fabio Broccatelli, Radha Ramakrishnan · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Considering Opportunities and Challenges When Implementing the Model Master File Framework – a Meeting Report
    Eleftheria Tsakalozou, Lanyan Fang, Erin Skoda, Timothy Nicholas, Sivacharan Kollipara, Ke Ren, Stella C. Grosser, Bhagwant D. Rege, Partha Roy, Hao Zhu et al. · 2025 · Pharmaceutical Research
  48. Pharmacokinetic Principles and Concepts
    Seth Kwabena Amponsah, Yahwant V. Pathak · 2025
  49. Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data
    Yumi Cleary, Nicolò Milani, Kayode Ogungbenro, Leon J Aarons, Aleksandra Galetin, Michael Gertz · 2025 · The AAPS Journal
  50. Integrated Pharmacokinetic Analysis in Discovery
    Emile P. Chen · 2025
  51. Advances in the Computational Prediction of Absorption Prediction of Pharmaceuticals
    Saba Khan, Aditi Pandey, Somesh Mishra, Roja Rani Budha, GSN Koteswara Rao · 2025 · Springer eBooks
  52. Advancing Pediatric Drug Safety: The Potential of Physiologically Based Pharmacokinetic Modeling
    Krishna Yadav · 2025 · Drug Metabolism and Bioanalysis Letters
  53. High-resolution fecal pharmacokinetic modeling in mice with orally administered antibiotics
    Rie Maskawa, Lena Takayasu, Hideki Takayasu C, Keiji Watanabe, Shusuke Takemine, Takashi Kakimoto, Kozue Takeshita, Seiko Narushima, Wataru Suda, Misako Takayasu · 2025 · Scientific Reports
  54. Revisiting the Role of Plasma-to-Blood Partitioning in Pharmacokinetics
    Amarinder Singh, Bernd Meibohm · 2025 · European Journal of Drug Metabolism and Pharmacokinetics
  55. Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors
    Yujie Wu, Weijie Kong, Jiayu Li, Xiaoqiang Xiang, Hao Liang, Dongyang Liu · 2025 · Pharmaceutics
  56. A Physiologically Based Pharmacokinetic Model for the Prediction of Plasma and Bone Tissue Exposure after Prophylactic Administration of Ampicillin/Sulbactam in Patients with Osteonecrosis of the Jaw
    Maximilian Stapf, Anton Straub, Valentin Carl Steinacker, Stefan Hartmann, Oliver Scherf‐Clavel · 2025 · Clinical Pharmacokinetics
  57. Development and characterisation of fast dispersible dimenhydrinate tablets: Compactional study and in-silico PBPK modeling
    Uroosa Maqbool, Farya Zafar, Riffat Yasmin, Huma Ali, Hira Akhtar, Rizwana Rehmat, Yumna Tahir, Iqra Haider, Shumaila Anwar, Javeria Ameer · 2025 · PLoS ONE
  58. Overcoming challenges in microbial drug factory scale-up
    Prakram Singh Chauhan, Tripti Dadheech, Arunika Saxena · 2025 · Elsevier eBooks
  59. Development and Validation of a Chinese Obesity-Specific Physiological Database for PBPK Modeling
    Ruwei Yang, Yujie Wen, Shengnan Zhang, Guoping Yang, Liyong Zhu, Qi Pei · 2025 · Clinical Pharmacokinetics
  60. P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modeling
    Mo’tasem M. Alsmadi · 2026 · Drug Metabolism and Disposition
  61. A minimal physiologically based pharmacokinetic model for predicting the metabolism of tenofovir prodrugs in the liver of human with fibrosis
    Hua He, Jinwei Zhu, Jiahao Chen, Huijie Guo, Simiao Yu, Huihui Hu, Xiaodan Hong, Hui Yu, Ting Wang, Guangji Wang et al. · 2026 · Drug Metabolism and Disposition
  62. The Significance of Model-Based Strategies in Drug Development throughout the Lifecycle and Regulatory Decision-Making
    Maitry Suthar, Neha Dandekar, Dipti H. Patel, Drashti Shah · 2026 · Current Clinical Pharmacology
  63. Revolutionizing Drug Development: Leveraging Computational Techniques for Enhanced Drug Testing
    T. Megala, P. Aurchana, R. VasanthSelvakumar, Malathy Shanmugam · 2026 · International Conference on Intelligent Data Communication Technologies and Internet of Things (IDCIoT)
  64. Ciblage des médicaments dans le foie : combinaison d'études pharmacocinétiques et de la modélisation pour optimiser les concentrations des médicaments dans les hépatocytes via le récepteur asialoglycoproteine
    Charlotte Bon · 2019
  65. PBPK modeling of doxorubicin-loaded polymeric nanoparticles : potential for clinical translation
    Fang-Ching Chao · 2023 · theses.fr (ABES)
  66. Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications
    Xinyue Chen, Zhoumeng Lin · 2026 · The Journal of Clinical Pharmacology
  67. Age-Driven Physiologically Based Pharmacokinetic Modeling of Empagliflozin: Toward Precision Dosing in Youth
    Gabriela Pereira Milhm, Fernanda de Lima Moreira, Barbara de Azevedo Abrahim-Vieira · 2026 · ACS Pharmacology & Translational Science
  68. Neuroimaging, computational, and artificial intelligence approaches in pesticide toxicity assessment
    Neha Gogia, Narendra Nath Jha · 2026 · Elsevier eBooks
  69. Gut microbiota–mediated cardiovascular effects of Gastrodia elata polysaccharides: resolving the bioavailability–efficacy paradox
    Ziyi Luo, Shunyao Zhu, Yiqing Lu, Wu Yili, Jiadong Xu · 2026 · Frontiers in Microbiology
  70. Pharmaceutical drug monitoring: the role of oral fluid sampling
    Sofia Soares, Tiago Rosado, Mário Barroso, Eugénia Gallardo · 2026 · Bioanalysis
  71. Pharmacokinetic Interactions
    Chandrakant Dixit, Deepika Paliwal, Ritam Mondal, Aman Thakur, Sk. Abdul Rahaman · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  72. From Executor to Orchestrator: The Pharmacology Scientist in the Age of Agentic AI
    Michael McCoy, Matt McCoy · 2026 · Clinical Pharmacology & Therapeutics
  73. A Physiologically Based Pharmacokinetic Model to Predict Potential Drug–Drug Interactions of TPN171 , a Novel Phosphodiesterase Type 5 Inhibitor
    Guanghui Tian, Tao Chen, Lei Li, Zhiqiang Wang, Hao Yang, Jiaxiang Juan, Yuanqin Duan, Jianghong Pei, Jingying Jia · 2026 · CPT Pharmacometrics & Systems Pharmacology
  74. Machine Learning in the Optimization of Pharmacokinetic Parameters
    Md Mobarak Hossain, Souvik Pore, Arkaprava Banerjee, Kunal Roy · 2026 · Royal Society of Chemistry eBooks
  75. Translational PBPK modeling and model-informed drug development of IDH305, a complex CYP3A4 modulator
    Yan Ji, 林雯, Tycho Heimbach, Andrea Pomrehn Myers · 2026 · Journal of Pharmaceutical Sciences
  76. Integrating in silico modeling into undergraduate education to enhance students competency in biopharmaceutics and pharmacokinetics
    Asma El-Magboub, Fatma Hassan, Marah Yousif, Marwa Mohamud, Alham Abuatiq · 2026 · Currents in Pharmacy Teaching and Learning
  77. Model‐informed dose optimization of etrasimod in ulcerative colitis across CYP2C9 genotypes and hepatic impairment
    Zihan Xu, Fangyi Qian, Yike Liu, Mengqi Jia, Lesheng Zhang, Hao Xue, Xiao Zhu, Xiaoqiang Xiang, Feng Zhen, Qingfeng He · 2026 · British Journal of Clinical Pharmacology
  78. CDK4/6 inhibitors: drug discovery, development, and classification
    Shankar Gupta, Chahat, Bhupinder Kumar, Manvendra Kumar, Muhammad Wahajuddin, Gaurav Joshi · 2026 · Elsevier eBooks
  79. Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib
    Lu Wang, Dandan Yang, Rong Shao, Jinliang Chen, Xiaodan Wang, Zheng Wang, Bo Jiang · 2026 · Clinical and Translational Science
  80. From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling
    Madison Parrot, Nuo Xu, Md. Adnan, Joseph Cave, Hamidreza Ghandehari, Elizabeth A. Nance, Venkata Yellepeddi · 2026 · Bioengineering & Translational Medicine
  81. PBPK-based exposure–response modeling of enzalutamide and its active metabolite N-desmethyl enzalutamide for the prediction of survival outcomes in patients with prostate cancer
    Jeongmin Ha, Hyojin Cho, Seongwon Park, Woojin Jung, Soyoung Lee, Hwi‐yeol Yun, Jung‐woo Chae · 2026 · Research Square
  82. Application of microdialysis and modelling approaches to predict drug concentration at the site of action
    Saivishal Daripelli, Vishwottam N. Kandikere, Anand Vijayakumar P R · 2026 · Indian Journal of Physiology and Pharmacology
  83. Dose Optimization of Cefazolin for Pediatric Patients with Renal Impairment Using Physiologically Based Pharmacokinetic Modeling (PBPK) in GastroPlus
    Abdelrahman Abdeen, Yousef A. Bin Jardan, Najia Rahim, Ruqaia AlShami, Raimar Löbenberg, Muhammad Sarfraz · 2026 · Pharmaceutics
  84. Translational PBPK Modeling and Exposure‐Response Analysis of AT ‐ RvD1 for Treating Sjögren's Disease
    Venkata Yellepeddi, Kihoon Nam, Frank Maslow, Olga J. Baker · 2026 · Clinical and Translational Science
  85. Network Biology: Current Status, Applications, Challenges, and Future Prospects
    Xinmeng Li, Laizhong Zhang, Yawen Ding, Kai Li, Shiyuan Chang, Linsen Pei, Zhengwei Li, Zhenzhen Chen · 2026 · MedComm
  86. Methadone: Historical success, modern challenges and lessons for opioid drug discovery
    Ennian Li, Preet Shah, Yan Zhang · 2026 · Drug Discovery Today
  87. Physiologically Based Pharmacokinetic Modeling Combined with Clinical Data to Explore the Pharmacokinetics of Voriconazole in Pediatric Patients with Hepatic Impairment
    Yiqi Yang, Jiayi Li, Ludan Zhang, Feng Zhang, Lin Song, Yuntao Jia · 2026 · Pharmaceutics